微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 32.19% | -10.71% | -1.3% | 34/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 32.61% | -10.4% | -3.61% | 34/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 33.83% | -13.69% | 1.49% | 29/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 33.34% | -12.12% | -7.52% | 35/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 36.05% | -7.35% | -0.96% | 33/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 36.4% | -8.42% | -7.15% | 35/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 39.2% | -9.97% | 3.34% | 27/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 37.93% | -12.23% | -2.51% | 33/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 38.91% | -18.31% | -2.11% | 30/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 39.75% | -12.64% | -8.72% | 29/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 43.54% | -5.95% | 0.75% | 23/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 43.22% | -1.09% | -9.25% | 26/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 47.63% | -0.32% | 4.69% | 16/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 45.49% | -3.14% | -1.73% | 22/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 46.3% | 27.26% | 5.95% | 14/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 43.7% | 2.75% | -8.55% | 23/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 47.78% | 7.87% | 1.73% | 10/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 46.97% | 7.94% | 29.11% | 14/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 36.38% | -12.18% | -14.46% | 16/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 42.53% | -6.74% | -3.99% | 26/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 44.3% | -7.83% | 1.8% | 15/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 43.51% | -6.47% | 5.05% | 17/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 41.42% | -25% | -9.17% | 14/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 45.6% | 66.47% | -5.11% | 14/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 48.06% | 46.01% | 3.3% | 8/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 46.52% | 16.85% | -15.77% | 13/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 55.23% | 34.87% | 101.62% | 6/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 27.39% | -43.7% | -16.77% | 37/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 32.91% | -30.65% | -17.33% | 21/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 39.81% | -17.36% | -2.78% | 19/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 40.95% | -13.77% | -15.84% | 12/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 48.66% | -1.88% | 2.53% | 8/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 47.46% | 1.27% | -1.49% | 5/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 48.18% | 3.93% | 1.45% | 6/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 47.49% | 3.42% | -4.24% | 3/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 49.59% | 0.46% | 5.82% | 5/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 46.86% | -0.33% | 1.09% | 5/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 46.36% | 2% | 0.96% | 6/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 45.92% | 2% | -6.98% | 4/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |